Epigenetic Modifiers

Epigenetic Modifiers is a class of antineoplastic agents that mediate changes in gene expression through reversible chemical modifications of DNA or histone proteins without altering the underlying nucleotide sequence.

763

Publications

39.8K

Citations

5.8K

Authors

1.6K

Institutions

Publications per year

2017–2026

396

Variants

Epigenetic DrugsEpigenetic Modifying Agents

Authors

5.8K

  1. LA
    Lucia Altucci

    University of Campania "Luigi Vanvitelli", Italy

    5 publications · 340 citations

    5

    h-index

  2. EM
    Eduardo M. Sotomayor

    Moffitt Cancer Center, United States

    4 publications · 223 citations

    4

    h-index

  3. KB
    Konstantinos Bladenopoulos

    National Agricultural Research Foundation, Greece

    4 publications · 248 citations

    4

    h-index

  4. AT
    Athanasios Tsaftaris

    Centre for Research and Technology Hellas, Greece

    4 publications · 248 citations

    4

    h-index

  5. RV
    Rajeev Vibhakar

    University of Colorado Denver, United States

    4 publications · 166 citations

    4

    h-index

1–5 of 5.8K

Venues

  1. PLoS ONE

    33 publications · 1.2K citations

    23

    h-index

  2. Oncotarget

    18 publications · 1.2K citations

    16

    h-index

  3. Clinical Epigenetics

    17 publications · 633 citations

    16

    h-index

  4. PubMed

    Repository · 23 publications · 762 citations

    15

    h-index

  5. Scientific Reports

    16 publications · 661 citations

    15

    h-index

1–5